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The replicase protein nsP2 of Semliki Forest virus (SFV) has a 648RRR nuclear localization signal and is
transported to the nucleus. SFV-RDR has a single amino acid change which disrupts this sequence and nsP2
nuclear transport. In BHK cells, SFV4 and SFV-RDR replicate to high titers, but SFV-RDR is less virulent in
mice. We compared the replication of SFV4 and SFV-RDR in adult mouse brain. Both SFV4 and SFV-RDR
were neuroinvasive following intraperitoneal inoculation. SFV4 spread rapidly throughout the brain, whereas
SFV-RDR infection was confined to small foci of cells. Both viruses infected neurons and oligodendrocytes.
Both viruses induced apoptosis in cultured BHK cells but not in the cells of the adult mouse brain. SFV-RDR
infection of mice lacking alpha/beta interferon receptors resulted in widespread virus distribution in the brain.
Thus, a component of the viral replicase plays an important role in the neuropathogenesis of SFV.
The molecular and cell biology of the alphavirus Semliki
Forest virus (SFV) have been extensively studied, as has the
pathogenesis of SFV infection in laboratory mice (6, 10). Gen-
erally, the virus is neuroinvasive, and extraneural inoculation
results in a high-titer plasma viremia with infection of central
nervous system (CNS) cells by virus passage across the blood-
brain barrier (24, 25, 11, 36). Strains of SFV vary in their
neurovirulence in adult mice. Irrespective of the route of in-
oculation, adult mice infected with the L10, V13, or prototype
strains or virus derived from the prototype molecular clone
SFV4 rapidly succumb to a fulminant encephalitis, whereas
adult mice infected with the A7 or A7(74) strain develop a
subclinical encephalitis (8, 27). The nominally avirulent strains
spread more slowly in the CNS, and host responses prevent
widespread fatal infection and eventually eliminate infectious
virus (7, 11), though they generate lesions of immune-medi-
ated demyelination (12, 37). In SJL mice these lesions are
active for many months (9, 35). In contrast to their differences
in adult mice, all strains of SFV are virulent in embryonic,
neonatal, and suckling mice (5, 11, 13, 15). For the adult-
avirulent strains A7 and A7(74) there is a sharp age-related
transition (22, 23). In suckling mouse brain and in culture,
many infected brain cells rapidly undergo apoptosis (3, 17),
whereas in immunocompromised adult mice, virus can persist
in CNS cells without any apparent cell death for many months
(4, 12). Age-related neurovirulence may be related to changes
in the propensity of CNS cells to undergo apoptosis on infec-
tion (2, 3).
The SFV4, A7, and A7(74) strains have been cloned and
sequenced (14, 16, 31, 32, 39, 40, 41). Between the strains there
are multiple changes scattered throughout the genome (41).
The difference in virulence between SFV4 and A7 or A7(74)
appears to be polygenic, and to date, changes in the E2 gene,
the 5 untranslated region, and the nsP3 gene have been shown
to be determinants of virulence between these particular
strains (32, 33, 40, 41). As with all viruses, there will also be
many other sites where changes in the genome sequence will
affect viral virulence.
Interestingly for a positive-strand RNA virus which repli-
cates in the cytoplasm, the SFV nsP2 nonstructural protein has
a nuclear targeting signal. This sequence, 648RRRV (the num-
bering refers to the SFV4 amino acid sequence), is present in
all three cloned and sequenced strains of the virus. In SFV4-
infected cells about half of the nsP2 synthesized is translocated
to the nucleus (19, 26, 29). nsP2 is involved at a number of
stages of viral RNA replication; it has single-stranded-RNA-
stimulated ATPase and GTPase activities, RNA triphos-
phatase activity, and RNA helicase activity; it regulates syn-
thesis of the 26S subgenomic RNA; it is involved in the
cessation of negative-strand synthesis; and it contains a papain-
like proteinase domain responsible for processing the non-
structural polyprotein (18, 20, 30, 38, 42). The mechanism by
which RNA viruses such as SFV trigger the apoptotic response
of the infected cell remain unclear; events in the nucleus would
be one possibility.
SFV-RDR virus has a single amino acid change, from SFV4
649R to D, which disrupts the nsP2 nuclear localization signal.
The engineering of this virus from the SFV4 cDNA infectious
clone has been described previously (28). In BHK-21 cells
transfected with infectious RNA transcribed from the SFV-
RDR plasmid, nsP2 expression is confined to the cytoplasm,
infected cells have only a partial shutoff of host cell DNA
synthesis, and there are only marginal differences in the one-
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step growth curves of the two viruses (28). In order to deter-
mine the importance of the nsP2 649R-to-D mutation and to
establish whether this has any role in neuroinvasion, neuro-
virulence, tropism, or ability of the virus to trigger apoptosis,
we compared the course of CNS infection in mice infected with
SFV-RDR and SFV4.
Four- to six-week-old female BALB/c mice, 129 mice, or 129
mice with a genetic disruption of the alpha/beta interferon
receptor gene (21) were kept under specific-pathogen-free
conditions in the animal unit at the University of Edinburgh
Laboratory for Clinical and Molecular Virology. Two groups
of 10 female BALB/c mice were inoculated intraperitoneally
with 200 PFU of SFV4 or SFV-RDR in 0.1 ml of phosphate-
buffered saline (PBS) containing 0.75% bovine serum albumin.
A further two groups of 10 female BALB/c mice were inocu-
lated intracerebrally with 50 PFU of SFV4 or SFV-RDR in
0.025 ml of PBS containing 0.75% bovine serum albumin.
Following intraperitoneal inoculation, mice were sampled at
days 4 and 7. Following intracerebral inoculation, mice were
sampled at days 2, 3, 4, and 7. In all cases, brains were removed
and bisected sagitally down the midline. One half of each brain
was snap frozen and stored (70°C) for the viral infectivity
assay, and the other half was immersion fixed in 4% phos-
phate-buffered formalin before being processed for paraffin-
based histology. Plaque assays were performed on subconflu-
ent monolayers of BHK-21 cells as described previously (11).
Paraffin-embedded sections at 5 m were cut onto adhesive-
coated slides and immunostained for viral antigens. Prior to
immunostaining, to increase sensitivity and resolution, an an-
tigen retrieval step was carried out by heating in a microwave
oven in 0.01 M citrate buffer. Sections were then rinsed in PBS,
fixed by immersion in paraformaldehyde lysine periodate for
20 min, and digested with proteinase K before immunostaining
using a rabbit polyclonal anti-SFV antiserum or staining with
the terminal deoxynucleotidyltransferase-mediated dUTP-bi-
otin nick end labeling (TUNEL) technique prior to immuno-
staining as described previously (11, 34).
Following intraperitoneal inoculation with 200 PFU of SFV4
or SFV-RDR, BALB/c mice survived at least 42 days, at which
time the study was terminated; these mice did not develop
clinical signs during this time. In contrast, BALB/c mice inoc-
ulated intracerebrally with SFV4 developed clinical signs
within 2 days and were all dead by 4 days (Table 1). Intrace-
rebral inoculation of SFV-RDR did not result in any mortality
FIG. 1. Brain virus titers determined by plaque assay on BHK-21 cells. Mice were inoculated intraperitoneally (A) or intracerebrally (B) with
200 PFU of SFV4 () or SFV-RDR (▫). SFV4 titers were significantly (P  0.05) higher than SFV-RDR titers by Student’s t test at several time
points following inoculation (intraperitoneal inoculation, P  0.065 and 0.007 on days 4 and 7, respectively; intracerebral inoculation, P  0.008
and 0.072 on days 2 and 3, respectively). Mice inoculated intracerebrally with SFV4 did not survive after day 3. The limit of detection of the assay
was 2.7 log (10) PFU/g of brain.
TABLE 1. Percent mortality and average survival time in
mice infected with SFV4 or SFV-RDR
Mouse straina
% Mortality
(avg survival time [days])
SFV4 SFV-RDR
BALB/c mice (i.p.) 0 0
BALB/c mice (i.c.) 100 (3.3) 0
129 IFN-/-R/ mice (i.p.) 0 0
129 IFN-/-R0/0 mice (i.p.) 100 (2.2) 100 (5.2)
a Mice inoculated intraperitoneally (i.p.) received 200 PFU; mice inoculated
intracerebrally (i.c.) received 50 PFU. Survival was observed for 42 days.
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or clinical signs over the 42-day study period. The brain virus
titers of the sampled mice are shown in Fig. 1. Both viruses
were neuroinvasive and entered the brain in all animals inoc-
ulated intraperitoneally. SFV4 brain virus titers were signifi-
cantly higher than SFV-RDR titers for both routes of infection
(Fig. 1). Immunostaining studies on the distribution and extent
of infection in the brain confirmed this finding, with many
more cells being infected by SFV4 than by SFV-RDR (Fig. 2A
FIG. 2. (A) Immunostaining for viral proteins showing widespread distribution of SFV4 in the cerebellum of an adult mouse, 3 days
postinfection. Cells in the all layers of the cerebellum are infected, including cells in the white matter tracts (wm), granule cells (g), and Purkinje
cells (arrow). Purkinje cell processes extending into the molecular layer (m) are clearly infected. (B) SFV-RDR in the cerebellum, 3 days
postinfection. As with SFV4, cells in all layers of the cerebellum are infected and the infection includes the dendritic tree of Purkinje cells, but
the number of infected cells is far lower (cf. panel A). (C) Higher-power view showing infection of a single cerebellar Purkinje cell. Both the cell
body (arrow) and dendritic tree contain viral proteins, SFV4, 3 days postinfection. Granule cells (g) and cells adjacent to the Purkinje cells which
are probably Bergmann glia cells () are also infected. (D) An SFV-RDR-positive cell (arrow) and its processes in the frontal cortex, 3 days
postinfection. Single positive cells or small foci of positive cells are characteristic of this infection. (E) Control immunostaining (brown) and
TUNEL staining (blue) in the olfactory bulb of a 4-day-old mouse infected intranasally (48 h earlier) with SFV A7(74). This section was stained
in the same assay as sections F and G. (F) Widespread infection of SFV4 includes white matter (wm) tracts and cells distributed in chains (arrow),
a characteristic of oligodendrocytes. Infected neurons often had large pale nuclei (). This section was also stained for TUNEL, and no
TUNEL-positive cells were observed (cf. panel E). (G) Widespread distribution of SFV-RDR in the cortex of an IFN-/-R0/0 mouse, 5 days
postinfection. This section was also stained for TUNEL, and no positive cells were observed (cf. panel E). (H) SFV-RDR infection of a BHK cell
in culture (48 h postinfection) immunostained for viral proteins (brown) in the cytoplasm and TUNEL (blue-black) in the nucleus (arrow).
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and B). SFV-RDR virus was restricted to replication in indi-
vidual cells or small groups of cells scattered throughout the
brain (Fig. 2D). This was particularly apparent following intra-
cerebral inoculation, where foci of infection were most fre-
quent around the needle tract and in the corpus callosum and
the deep layers of the cortex close to the site of inoculation. No
major differences in virus cell-type tropism were observed.
Both viruses infected cells which based on their morphology
were clearly neurons, for example, cerebellar Purkinje cells,
and cells distributed in chains in the white matter, presumably
oligodendrocytes (Fig. 2C and F). Neither strain of virus re-
sulted in positive staining of ependymal, meningeal, or choroid
plexus cells.
The difference in brain virus titers and the extent of spread
of these two viruses was marked and could have resulted from
a number of factors. One possibility is that SFV-RDR is inca-
pable of widespread brain infection; alternatively, there could
have been insufficient time for this virus to become widespread
before its control by host responses. To distinguish between
these possibilities, the course of SFV4 and SFV-RDR infection
was investigated in groups of 10 alpha/beta interferon receptor
knockout (IFN-/-R0/0) and parental (wild-type) 129 mice
(21). Disruption of the single alpha/beta interferon receptor
results in an absence of alpha/beta interferon responses. Intra-
peritoneal inoculation of 200 PFU of SFV4 into IFN-/-R0/0
mice resulted in death of all mice within 3 days with minimal
brain infection, whereas intraperitoneal inoculation of 200
PFU of SFV-RDR into IFN-/-R0/0 mice resulted in death
between 4 and 6 days. As with BALB/c mice, wild-type 129
mice, which have an intact interferon system, survived intra-
peritoneal infection with both strains of virus (Table 1). Ex-
amination of the brains of moribund SFV-RDR-infected IFN-
/-R0/0 mice at 5 days revealed widespread infection in the
frontal cortex (Fig. 2G), brain stem, pons, and thalamus with
infection of ependymal cells, meningeal cells, cerebellar Pur-
kinje cells, cerebellar granule cells, and oligodendrocytes.
In adult mouse brain, in the absence of appropriate immune
responses the avirulent SFV A7(74) strain can persist for many
months (4, 12), and in contrast to the situation in the devel-
oping brain, infected cells do not undergo apoptosis (2). To
ascertain whether SFV4 infection of adult brain cells results in
apoptosis and whether the nsP2 649R-to-D mutation changes
this situation, brain sections were stained by the TUNEL tech-
nique to detect apoptotic cells and immunostained to detect
virally infected cells. Sections of SFV A7(74)-infected neonatal
mouse brain were used as positive controls and showed clear
TUNEL staining (Fig. 2E), as shown previously (3). Fixed
cultures of SFV4- and SFV-RDR-infected BHK-21 cells were
also double labeled. In both the SFV4- and SFV-RDR-in-
fected adult BALB/c mouse brains, the majority of SFV pro-
tein-positive cells had the morphologic appearance of neurons
and showed enlarged palely staining nuclei (Fig. 2F). None of
these infected cells were TUNEL positive. Double labeling was
also carried out on sections from the brains of SFV-RDR-
infected IFN-/-R0/0 mice, and again, neurons with enlarged
palely staining nuclei but no TUNEL-positive infected cells
were observed (Fig. 2G). In contrast to mature neurons,
both SFV4- and SFV-RDR-infected BHK-21 cells exhibited
TUNEL-positive nuclei (Fig. 2H). These results demonstrate
that an intact RRR nuclear localization sequence is not re-
quired for triggering of apoptosis in SFV-infected BHK-21
cells or for the reduced apoptosis observed in SFV-infected
adult brain neurons.
In conclusion, an intact nsP2 649RRR sequence is not re-
quired in cultured BHK-21 cells for apoptosis or in adult mice
for neuroinvasion, determination of CNS cell tropism, or in-
hibition of apoptosis. In contrast, an intact nsP2 RRR se-
quence enhances spread of virus in the mature mouse brain,
exacerbating neuropathology and increasing virulence. Thus, a
single mutation in the multifunctional RNA replicase protein
can limit virus spread in the brain, indicating the importance
for pathogenesis of events associated with RNA replication or
nsP2 nuclear transport. The nsP3 replicase protein has been
shown to be important in the attenuated neurovirulence of the
A7(74) strain of SFV (41). We recently constructed an SFV
mutant with an internal deletion in nsP3 which also has atten-
uated neurovirulence in mice (43). Further support for the
importance of RNA replicase components in neuropathogen-
esis comes from the observation that inhibition of palmitoyl-
ation of nsP1 also attenuates SFV neurovirulence (1). Our
present results obtained with mice with no functional alpha/
beta interferon system show that mutation of the nsP2 RRR
sequence does not prevent virus spread but results in a lower
rate of spread. Thus, RNA replication as such is not inhibited,
but it may be slowed sufficiently in neuronal cells for the
interferon system to limit the infection. This effect could also
underlie the attenuating changes in nsP1 and nsP3. Further
characterization of these mutant viruses in neuronal cultures as
well as in immunodeficient mice is needed to identify the role
of the RNA replication apparatus in the neuropathogenicity of
this virus.
REFERENCES
1. Ahola, T., P. Kujala, M. Tuittila, T. Blom, P. Laakkonen, A. Hinkkanen, and
P. Auvinen. 2000. Effects of palmitoylation of replicase protein nsP1 on
alphavirus infection. J. Virol. 74:6725–6733.
2. Allsopp, T. E., and J. K. Fazakerley. 2000. Altruistic cell suicide and the
specialized case of the virus-infected central nervous system. Trends Neuro-
sci. 23:284–290.
3. Allsopp, T. E., M. F. Scallan, A. Williams, and J. K. Fazakerley. 1998. Virus
infection induces neuronal apoptosis: a comparison with trophic factor with-
drawal. Cell Death Differ. 5:50–59.
4. Amor, S., M. F. Scallan, M. M. Morris, H. Dyson, and J. K. Fazakerley. 1996.
Role of immune responses in protection and pathogenesis during Semliki
Forest virus encephalitis. J. Gen. Virol. 77:281–291.
5. Atkins, G. J., J. Carter, and B. J. Sheahan. 1982. Effect of alphavirus
infection on mouse embryos. Infect. Immun. 38:1285–1290.
6. Atkins, G. J., B. J. Sheahan, and P. Liljestro¨m. 1999. The molecular patho-
genesis of Semliki Forest virus: a model virus made useful. J. Gen. Virol.
80:2287–2297.
7. Balluz, I. M., G. M. Glasgow, H. M. Killen, M. F. Mabruk, B. J. Sheahan,
and G. J. Atkins. 1993. Virulent and avirulent strains of Semliki Forest virus
show similar cell tropism for the murine central nervous system but differ in
the severity and rate of induction of cytolytic damage. Neuropathol. Appl.
Neurobiol. 19:233–239.
8. Bradish, C. J., K. Allner, and H. B. Maber. 1971. The virulence of original
and derived strains of Semliki Forest virus for mice, guinea pigs and rabbits.
J. Gen. Virol. 12:141–160.
9. Donnelly, S. M., B. J. Sheahan, and G. J. Atkins. 1997. Long-term effects of
Semliki Forest virus infection in the mouse central nervous system. Neuro-
pathol. Appl. Neurobiol. 23:235–241.
10. Fazakerley, J. K., S. Amor, and A. A. Nash. 1997. Animal model systems of
MS, p. 255–273. In W. C. Russell (ed.), Molecular biology of multiple
sclerosis. John Wiley & Sons, New York, N.Y.
11. Fazakerley, J. K., S. Pathak, M. Scallan, S. Amor, and H. Dyson. 1993.
Replication of the A7(74) strain of Semliki Forest virus is restricted in
neurons. Virology 195:627–637.
12. Fazakerley, J. K., and H. E. Webb. 1987. Semliki Forest virus-induced,
immune-mediated demyelination-adoptive transfer studies and viral persis-
tence in nude mice. J. Gen. Virol. 68:377–385.
VOL. 76, 2002 NOTES 395
13. Fleming, P. 1977. Age-dependent and strain-related differences of virulence
of Semliki Forest virus in mice. J. Gen. Virol. 37:93–105.
14. Garoff, H., A. Frischauf, K. Simons, H. Lehrach, and H. Delius. 1980.
Nucleotide sequence of cDNA coding for Semliki Forest virus membrane
glycoproteins. Nature 288:236–241.
15. Gates, M. C., B. J. Sheahan, M. A. O’Sullivan, and G. J. Atkins. 1985. The
pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for
weanling mice and primary mouse brain cell cultures. J. Gen. Virol. 66:2365–
2373.
16. Glasgow, G. M., H. M. Killen, P. Liljestrom, B. J. Sheahan, and G. J. Atkins.
1994. A single amino-acid change in the E2 spike protein of a virulent strain
of Semliki Forest virus attenuates pathogenicity. J. Gen. Virol. 75:663–668.
17. Glasgow, G. M., M. M. McGee, B. J. Sheahan, and G. J. Atkins. 1997. Death
mechanisms in cultured cells infected by Semliki Forest virus. J. Gen. Virol.
78:1559–1563.
18. Gomez de Cedron, M., N. Ehsani, M. Mikkola, J. A. Garcia, and L. Ka¨a¨ri-
a¨inen. 1999. RNA helicase activity of Semliki Forest virus replicase protein
NSP2. FEBS Lett. 448:19–22.
19. Kujala, P., M. Rikkonen, T. Ahola, M. Kelve, M. Saarma, and L. Ka¨a¨ria¨inen.
1997. Monoclonal antibodies specific for Semliki Forest virus replicase pro-
tein nsP2. J. Gen. Virol. 78:343–351.
20. Merits, A., L. Vasiljeva, T. Ahola, L. Ka¨a¨ria¨inen, and P. Auvinen. 2001.
Proteolytic processing of Semliki Forest virus-specific nonstructural polypro-
tein by nsP2 protease. J. Gen. Virol. 82:765–773.
21. Muller, U., U. Steinhoff, L. F. L. Reis, S. Hemmi, J. Pavlovic, R. Zinkernagel,
and M. Aguet. 1994. Functional role of type I and type II interferons in
antiviral defense. Science 264:1918–1924.
22. Oliver, K. R., and J. K. Fazakerley. 1998. Transneuronal spread of Semliki
Forest virus in the developing mouse olfactory system is determined by
neuronal maturity. Neuroscience 82:867–877.
23. Oliver, K. R., M. F. Scallan, H. Dyson, and J. K. Fazakerley. 1997. Suscep-
tibility to a neurotropic virus and its changing distribution in the developing
brain is a function of CNS maturity. J. Neurovirol. 3:38–48.
24. Pathak, S., and H. E. Webb. 1974. Possible mechanisms for the transport of
Semliki Forest virus into and within mouse brain: an electron microscopic
study. J. Neurol. Sci. 23:175–184.
25. Pathak, S., and H. E. Webb. 1980. The entry and the transport of arboviruses
into and throughout mouse brain: an electron-microscopic study. Electron
Microsc. 2:492–493.
26. Pera¨nen, J., M. Rikkonen, P. Liljestro¨m, and L. Ka¨a¨ria¨inen. 1990. Nuclear
localization of Semliki Forest virus nonstructural protein nsP2. J. Virol.
64:1888–1896.
27. Pusztai, R., E. Gould, and H. Smith. 1971. Infection pattern in mice of an
avirulent and virulent strain of Semliki Forest virus. Br. J. Exp. Pathol.
52:669–677.
28. Rikkonen, M. 1996. Functional significance of the nuclear-targeting and
NTP-binding motifs of Semliki Forest virus nonstructural protein nsP2. Vi-
rology 218:352–361.
29. Rikkonen, M., J. Peranen, and L. Ka¨a¨ria¨inen. 1992. Nuclear and nucleolar
targeting signals of Semliki Forest virus nonstructural protein nsP2. Virology
189:462–473.
30. Rikkonen, M., J. Peranen, and L. Ka¨a¨ria¨inen. 1994. ATPase and GTPase
activities associated with Semliki Forest virus nonstructural protein nsP2.
J. Virol. 68:5804–5810.
31. Santagati, M. G., P. V. Itaranta, P. R. Koskimies, J. A. Ma¨a¨tta¨, A. Salmi, and
A. E. Hinkkanen. 1994. Multiple repeating motifs are found in the 3-
terminal non-translated region of Semliki Forest virus A7 variant genome.
J. Gen. Virol. 75:1499–1504.
32. Santagati, M. G., J. A. Maatta, P. V. Itaranta, A. A. Salmi, and A. E.
Hinkkanen. 1995. The Semliki Forest virus E2 gene as a virulence determi-
nant. J. Gen. Virol. 75:47–52.
33. Santagati, M. G., J. A. Ma¨a¨tta¨, M. Roytta, A. A. Salmi, and A. E. Hinkkanen.
1998. The significance of the 3-nontranslated region and E2 amino acid
mutations in the virulence of Semliki Forest virus in mice. Virology 243:66–
77.
34. Scallan, M. F., T. E. Allsopp, and J. K. Fazakerley. 1997. Bcl-2 acts early to
restrict Semliki Forest virus replication and delays virus-induced pro-
grammed cell death. J. Virol. 71:1583–1590.
35. Smyth, J. M., B. J. Sheahan, and G. J. Atkins. 1990. Multiplication of
virulent and demyelinating Semliki Forest virus in the mouse central nervous
system: consequences in BALB/c and SJL mice. J. Gen. Virol. 71:2575–2583.
36. Soilu-Hanninen, M., J. P. Eralinna, V. Hukkanen, M. Roytta, A. A. Salmi,
and R. Salonen. 1994. Semliki Forest virus infects mouse brain endothelial
cells and causes blood-brain barrier damage. J. Virol. 68:6291–6298.
37. Subak-Sharpe, I., H. Dyson, and J. K. Fazakerley. 1993. In vivo depletion of
CD8 T cells prevents lesions of demyelination in Semliki Forest virus
infection. J. Virol. 67:7629–7633.
38. Suopanki, J., D. L. Sawicki, S. G. Sawicki, and L. Ka¨a¨ria¨inen. 1998. Regu-
lation of alphavirus 26S mRNA transcription by replicase component nsP2.
J. Gen. Virol. 79:309–319.
39. Takkinen, K. 1986. Complete nucleotide-sequence of the nonstructural pro-
tein genes of Semliki Forest virus. Nucleic Acids Res. 14:5667–5682.
40. Tarbatt, C. J., G. M. Glasgow, D. A. Mooney, B. J. Sheahan, and G. J. Atkins.
1997. Sequence analysis of the avirulent, demyelinating A7 strain of Semliki
Forest virus. J. Gen. Virol. 78:1551–1557.
41. Tuittila, M. T., M. G. Santagati, M. Roytta, J. A. Maatta, and A. E. Hink-
kanen. 2000. Replicase complex genes of Semliki Forest virus confer lethal
neurovirulence. J. Virol. 74:4579–4589.
42. Vasiljeva, L., A. Merits, P. Auvinen, and L. Ka¨a¨ria¨inen. 2000. Identification
of a novel function of the alphavirus capping apparatus. RNA 5-triphos-
phatase activity of nsP2. J. Biol. Chem. 275:17281–17287.
43. Vihinen, H., T. Ahola, M. Tuittila, A. Merits, and L. Ka¨a¨ria¨inen. 2001.
Elimination of phosphorylation sites of Semliki Forest virus replicase protein
nsP3. J. Biol. Chem. 276:5745–5752.
396 NOTES J. VIROL.
